Matt Callahan

Matt Callahan is the Chairman of Botanix Pharma and has more than 20 years of pharmaceutical, venture capital and legal experience.  He is a co-inventor of another drug delivery technology which has been successfully used in 3 FDA approved products and he has co-founded a number of pharmaceutical and biotech companies including iCeutica Inc, Glycan Bioscience LLC and Dimerix Bioscience Limited (ASX:DMX).  Mr Callahan was also formerly the General Manager and General Counsel of Australian technology and licensing company ipernica (now ASX listed company Nearmap Ltd), where he was responsible for the licensing programs that have generated more than $120M in revenue.  He remains a partner of seed venture capital fund Stone Ridge Ventures focused on Australian sourced technology and life sciences opportunities.